Company Filing History:
1 out of 1 
1 out of 3,578 
Years Active: 2022
Title: The Innovative Discoveries of Jing Cui: A Pioneer in Cancer Research
Introduction: Jing Cui, based in Potomac, Maryland, has made significant contributions to the field of cancer research through his innovative work in pharmaceuticals. With a focus on combating metastasis, his research has added a valuable perspective to cancer treatment methodologies.
Latest Patents: Jing Cui holds a patent for the "Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis." This pharmaceutical composition, which includes formulations of 4′-O-isovalerylspiramycin I, II, and III, demonstrates effectiveness in counteracting tumorigenesis. The patented solution works by inhibiting selenoprotein H, triggering genomic instability and cell-cycle arrest in cancer cells, thereby reducing or preventing metastasis.
Career Highlights: Throughout his career, Jing Cui has been associated with prominent organizations that push the boundaries of scientific research. Notably, he has worked with Asclea Corporation and the United States of America, as represented by the Secretary of the Department of Health and Human Services Office of Technology Transfer at the National Institutes of Health. His experiences at these institutions have enriched his expertise and facilitated groundbreaking research.
Collaborations: Collaboration is key in the scientific community, and Jing Cui has partnered with esteemed colleagues such as Enhong Jiang and Zhengping Zhuang. These collaborative efforts have enhanced the quality of research output and fostered innovative approaches to combating cancer.
Conclusion: Jing Cui's dedication to advancing cancer therapeutics through his innovative inventions marks him as a significant figure in pharmaceutical research. His patent focusing on isovalerylspiramycins offers hope for improving cancer treatment outcomes and highlights the importance of continued research and collaboration in the fight against cancer. As the landscape of medicine evolves, contributions from inventors like Jing Cui will undoubtedly pave the way for more effective interventions in cancer care.